期刊
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
卷 42, 期 3, 页码 859-875出版社
KARGER
DOI: 10.1159/000478628
关键词
H2S; Atherosclerosis; CSE; ApoE; Gasotransmitter
资金
- National Scientific and Technological Major Project [2012ZX09501001-001-003, 2012ZX09103101-064]
- National Natural Science Foundation of China [81573421, 81330080, 81173054]
- Shanghai Committee of Science and Technology of China [14JC1401100]
- Education Commission of Shanghai Municipality [ZDSYS14005]
Hydrogen sulfide (H2S) is now admitted as a third gasotransmitter together with nitric oxide (NO) and carbon monoxide (CO), albeit it was originally considered as a foul and poisonous gas. Endogenous H2S production in mammalian cells is counting on the three enzymes acting on cysteine. Involvement of H2S in various physiological and pathological processes has been extensively studied in the last fifteen years. Mounting evidence suggests that H2S is able to protect against atherosclerosis development and progression. Exogenous H2S supplement has salutary effects on atherogenesis, and reduction of the endogenous H2S level accelerates atherosclerosis. The anti-atherosclerotic mechanisms of H2S have been descried in different aspects, including endothelium preservation, antioxidative action, anti-inflammatory responses, vasorelaxation, regulation of ion channels, etc. However, further investigation is still needed to help us gain more insights into the fundamental underlying mechanisms, and that will allow us to design better therapeutic applications of H2S in the treatment of atherosclerosis. (C) 2017 The Author(s) Published by S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据